ZEGFROVY

Live / Registered — Registered (as of 14 Jan 2025)

What this means for you

Registered since 14 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97447022
Registration number
7654958
Mark type
Design + words
Filed
07 Jun 2022
Published for opposition
27 Jun 2023
Registered
14 Jan 2025
Attorney of record
Michael T. Smith

Goods and services

  • Class 005 — Pharmaceuticals: Acids for pharmaceutical purposes; adjuvants for medical purposes; agricultural fungicide; aluminum acetates for pharmaceutical purposes; amino acids for medical purposes; analgesics; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; antibiotic, sunburn and anti-inflammatory ointments for pharmaceutical purposes; antibiotics; antioxidant pills for medical use; antiseptics; astringents for medical purposes; bacterial culture mediums; bacterial poisons; bacterial preparations for medical purposes for researching of human illnesses; bacteriological research preparation, namely, preparations of reports for anti-tumor treatment for medical purposes; balsamic preparations for medical purposes; biological agents for the treatment of cancer; biological preparations for medical purposes for treatment of human illnesses; biological tissue cultures for medical purposes; blood for medical purposes; blood plasma; bouillons for bacteriological cultures; bronchodilating preparations; by-products of the processing of cereals for dietetic or medical purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; candy for medical purposes; candy for pharmaceutical purpose for treatment of the cough; capsules made of dendrimer-based polymers for medicinal preparations for the mouth, for pharmaceuticals purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations as medicines for medical purposes, namely, for anti-tumor treatment; chemical preparations for pharmaceutical purposes for the treatment of human illnesses, namely, anti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; chemico-pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; chewing gum for medical purposes; Chinese medicine nostrum for the treatment of tumors in humans; collyrium; contact lens cleaning preparations; contact lens disinfectant; contact lenses care solution; cough pastilles for pharmaceutical purposes; crystallized rock sugar for medical purposes; depuratives for the body; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic substances of low sugar and salt adapted for medical use; digestives for pharmaceutical purposes; drugs for medical purposes for treatment of human illnesses, namely, anti-tumor treatment; enzyme preparations for medical purposes; enzymes for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; eye drops; filled portable medicine cases, comprised of pharmaceuticals for treatment of human illnesses, namely, anti-tumor treatment; first-aid boxes, filled; fungicides; gelatine for medical purposes, namely, gelatin capsules sold empty; germicides; herbal teas for medicinal purposes; insect killing preparations in the nature of pesticides; insecticidal veterinary washes; insecticides; isotopes for medical purposes; media for bacteriological cultures; medical diagnosis reagent; medical probiotic supplements; medicated eye-washes; medicated lozenges for pharmaceutical purposes; medicinal drinks; medicinal hair growth preparations; medicinal preparations for the mouth to be applied in the form of capsules; medicines for alleviating constipation; medicines for dental purposes; mineral, bath and sodium salts for medical purposes; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; opotherapy preparations; organotherapy preparations; pesticides; petroleum jelly for medical purposes; pharmaceutical blood preparations, namely, a blood clotting aid and delivery system for use in human medicine; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; pharmaceutical preparations for skin care; pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; pharmaceutical preparations, namely, elixirs for anti-tumor treatment; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposes, namely, anti-tumor treatment; preparations for destroying noxious animals; protein dietary supplements; radioactive substances for medical purposes; radiological contrast substances for medical purposes; rat poison; raw material drugs, namely, pharmaceuticals for anti-tumor treatment; reagent paper for medical purposes; reagent paper for veterinary purposes; rubbing alcohol; solutions for contact lenses; stem cells for medical purposes; sterilizing preparations; styptic preparations; tonics being pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; vaccine preparations; bacteriological preparations for veterinary use; cultures of microorganisms for veterinary use; chemical reagents for veterinary purposes; veterinary preparations for the treatment of intestinal bacteria; diagnostic preparations for veterinary use

Owner

Prosecution history

  • 14 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 14 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
  • 28 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 28 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 02 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 02 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 02 Oct 2024 — ASSIGNED TO LIE
  • 11 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 15 Mar 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 15 Mar 2024 — NON-FINAL ACTION E-MAILED
  • 15 Mar 2024 — SU - NON-FINAL ACTION - WRITTEN
  • 29 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
  • 06 Feb 2024 — USE AMENDMENT FILED
  • 29 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 06 Feb 2024 — TEAS STATEMENT OF USE RECEIVED

View this trademark record on Marksy